Global Vaccine Market to reach USD 60 Billion, by the end of year 2022

“Global Vaccines Market to reach US$ 60 Billion by the year 2022.”
Global Vaccines Market & Forecast (14 Vaccines Market, Number of People Immunized Doses of Vaccines Administered) is the 8th edition of market research report published by Renub Research on Global Vaccines Market. This is a 318 page report with 193 Figures and 44 Tables provides data of Global Vaccine Market (Adult & Pediatrics), People Immunized, Number of Vaccine Doses Administered (Disease wise) & Key Players.

Global vaccine market is probable to reach US$ 60 Billion by the end of year 2022 says the recent report published by Renub Research entitled “Global Vaccines Market & Forecast” by 14 vaccines (Influenza, Cervical Cancer, Zoster, MMRV, Pneumococcal, Meningococcal, Hepatitis, Dtap, Travel and Miscellaneous, Haemophilus Influenzae Type b (Hib), Combos, Polio, Rotavirus, Varicella), number of immunized person, number of vaccines doses administered and company sales – forecast to 2022.

Get Free 10% Customization in this Report

Click here for summary of the report with TOC:

Vaccines Prevent Diseases

With so many diseases in the world, there needs to be something to protect people from getting sick and even dying. So, we have vaccines to protect ourselves from getting sick. In simple words, Vaccines immunize and protect people from several serious diseases such as measles, meningitis, pneumonia, Influenza, rubella and polio.

View more vaccines market reports by Renub Research

Era of Vaccines

A number of vaccines have been developed (e.g. cervical cancer and dengue vaccine) and several others are already on its way to hit the market at earliest (e.g. malaria and zika vaccines), making last 15 years the most productive in the history of vaccines development.

Industrialized countries already have a robust system of immunization programmes while developing countries are trying their best to implement such programmes to save a million lives.


Request a free sample copy of the report:

Vaccine Market Briefing

Pneumococcal vaccine is the largest segment for vaccine and it terms of value it accounts more than US$ 7 Billion in 2016. The Pneumococcal vaccine sale is primarily driven by increasing utilization of Pneumococcal vaccines products worldwide, and especially in the US, where the Advisory Committee on Immunization Practices (ACIP) strictly recommends its inoculation. While there is also a considerable boost in the market size of Cervical Cancer Vaccine as many countries around the world efficiently focused on the causalities caused by this disease, thus recommend all women must get Cervical Cancer Vaccine to prevent cervical cancer.

Analyst View

Vaccination is one of the most prominent and conservative of all healthcare interventions. It not only prevents illness and disability but also to transform, lives – giving each one a chance to grow up healthy and improve their lifestyle. Vaccines and proper vaccination save millions of lives every year.

Browse Related Reports :
Global Influenza Vaccine Market

About Us

Renub Research is a Market Research and Consulting Company. We have more than 10 years of experience especially in international Business-to-Business Researches, Surveys and Consulting. We provide wide range of business research solutions that helps companies in making better business decisions. Our clients rely on our market analysis and data to make informed knowledgeable decisions. Our pertinent analysis helps consultants, bankers and executives to make informed and correct decisions.


Media Contact
Company Name: Renub Research
Contact Person: Rajat Gupta
Phone: 6783020700
Address:225 Kristie Ln
City: Roswell
State: GA
Country: United States